---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-137894"
form_type: "8-K"
ticker: "IOBTQ"
cik: "0001865494"
company_name: "IO Biotech, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:32:47.469495+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# IO Biotech stockholders elect David Smith to board, ratify EY as auditor

## Summary
- David Smith elected as Class I director with 40,444,898 votes for, 3,010,542 withheld, 8,622,498 broker non-votes.
- Ratification of EY Godkendt Revisionspartnerselskab as independent auditor: 51,581,966 for, 183,927 against, 312,045 abstain.
- Annual Meeting held June 5, 2025; both proposals approved.

## SEC filing metadata
- accession: 0001193125-25-137894
- form_type: 8-K
- ticker: IOBTQ
- cik: 0001865494
- company_name: IO Biotech, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865494/000119312525137894/0001193125-25-137894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865494/000119312525137894/d908239d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-137894
- JSON: https://secwatch.observer/filing/0001193125-25-137894.json
- Plain text: https://secwatch.observer/filing/0001193125-25-137894.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.